Last reviewed · How we verify
NCT07106203: PLB-PEDPNEU
Effect of Pursed-Lip Breathing on Physiological Parameters and Discharge Readiness in Children With Pneumonia
NA trial testing Pursed-Lip Breathing (PLB) in Pneumonia in 66 participants. Not yet recruiting.
1 February 2026
Quick facts
| Lead sponsor | Ataturk University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 1 November 2025 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 May 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Pursed-Lip Breathing (PLB)
Conditions studied
- Pneumonia — all drugs for Pneumonia →
Sponsor
Ataturk University
Who can join
Adults 3 to 4, any sex, with Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effects of Pursed-Lip Breathing (PLB) exercises on physiological parameters (such as respiratory rate, heart rate, and oxygen saturation) and discharge readiness in children diagnosed with pneumonia. The study is designed as a randomized controlled trial involving pediatric patients between the ages of 3 and 4. The intervention includes guided PLB exercises performed twice daily for three consecutive days. Data will be collected before and after each session to assess changes in physiological measures and readiness for hospital discharge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07106203
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pneumonia
Currently open trials in the same condition.
- NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
- NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
- NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
- NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
- NCT06911658 — Infectious Complications After Esophagectomy · recruiting
Other Ataturk University trials
Trials by the same sponsor.
- NCT07518537 — Bulk-Fill Composite Restorations: Clinical Evaluation · NA · not yet recruiting
- NCT07241156 — Creative Drama on Gender Role Stress, Attitudes Toward Violence Against Women, and Aggression · NA · not yet recruiting
- NCT07451418 — The Effect of Mindfulness Compassionate Living Training on Unwanted Pregnancies · NA · not yet recruiting
- NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
- NCT07375277 — Effects Of Biceps Transposition Without Tenotomy For Augmentation Of Massive Rotator Cuff Repairs · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07106203 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ataturk University
- Last refreshed: 6 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07106203.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing